Inventor · disambiguated record
Steven A. Feldman
Also filed as: FELDMAN STEVEN A
5 granted patents·5 pending applications·50 citations·filing 2012–2023
75Inventor score
Top patents by PatentIndex Score
10 records- 0196US9359447B2Anti-mesothelin chimeric antigen receptorsUS HEALTH·Filed 2013·Granted Jun 7, 2016·44 cites·27 claims
- 0289US11951131B2Anti-SLAMF7 chimeric antigen receptorsUS HEALTH·Filed 2019·Granted Apr 9, 2024·4 cites·16 claims
- 0387US11306131B2T cell receptors recognizing HLA-A1- or HLA-CW7-restricted mageUS HEALTH·Filed 2018·Granted Apr 19, 2022·2 cites·26 claims
- 0481US2024158748A1Methods for producing autologous t cells useful to treat b cell malignancies and other cancers and compositions thereofKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 0578US12441778B2T cell receptors recognizing HLA-A1-restricted MAGE-A3US HEALTH·Filed 2022·Granted Oct 14, 2025·0 cites·22 claims
- 0655US2019032011A1Methods for producing autologous t cells useful to treat b cell malignancies and other cancers and compositions thereofKITE PHARMA INC·Filed 2018·Application pending·0 cites
- 0755US2014378389A1T cell receptors recognizing hla-a1- or hla-cw7-restricted mageUS HEALTH·Filed 2012·Application pending·0 cites
- 0847US12227554B2Methods for selectively expanding cells expressing a TCR with a murine constant regionUS HEALTH·Filed 2018·Granted Feb 18, 2025·0 cites·17 claims
- 0945US2015344844A1Methods for producing autologous t cells useful to treat b cell malignancies and other cancers and compositions thereofBETTER MARC·Filed 2015·Application pending·0 cites
- 1035US2016333422A1Anti-ny-br-1 polypeptides, proteins, and chimeric antigen receptorsUS HEALTH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven A. Feldman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →